142 related articles for article (PubMed ID: 18317962)
1. OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative).
García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Cancer Invest; 2008; 26(3):222-9. PubMed ID: 18317962
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
3. IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma.
Garcia-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Histopathology; 2005 Jul; 47(1):82-9. PubMed ID: 15982327
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
Underhill-Day N; Heath JK
Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
[TBL] [Abstract][Full Text] [Related]
5. Expression of oncostatin M and its receptors in normal and cirrhotic human liver.
Znoyko I; Sohara N; Spicer SS; Trojanowska M; Reuben A
J Hepatol; 2005 Nov; 43(5):893-900. PubMed ID: 16169119
[TBL] [Abstract][Full Text] [Related]
6. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
Malaval L; Liu F; Vernallis AB; Aubin JE
J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
[TBL] [Abstract][Full Text] [Related]
7. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
Hui W; Bell M; Carroll G
Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
[TBL] [Abstract][Full Text] [Related]
8. Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation.
Song H; Lim H
Reproduction; 2006 Feb; 131(2):341-9. PubMed ID: 16452727
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of members of the cytokine receptor superfamily on breast cancer cells.
Douglas AM; Goss GA; Sutherland RL; Hilton DJ; Berndt MC; Nicola NA; Begley CG
Oncogene; 1997 Feb; 14(6):661-9. PubMed ID: 9038373
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M and leukemia inhibitory factor regulate the growth of normal human breast epithelial cells.
Grant SL; Douglas AM; Goss GA; Begley CG
Growth Factors; 2001; 19(3):153-62. PubMed ID: 11811789
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor beta (TGFbeta) in benign and carcinomatous (in situ and infiltrating) human breast: implications in malignant transformations.
García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Cancer Invest; 2006 Mar; 24(2):119-25. PubMed ID: 16537179
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells.
Repovic P; Fears CY; Gladson CL; Benveniste EN
Oncogene; 2003 Nov; 22(50):8117-24. PubMed ID: 14603252
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes.
Weiss TW; Speidl WS; Kaun C; Rega G; Springer C; Macfelda K; Losert UM; Grant SL; Marro ML; Rhodes AD; Fuernkranz A; Bialy J; Ullrich R; Holzmann P; Pacher R; Maurer G; Huber K; Wojta J
Cardiovasc Res; 2003 Sep; 59(3):628-38. PubMed ID: 14499864
[TBL] [Abstract][Full Text] [Related]
14. Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: Involvement of regulation of LIF and its receptor expression.
Kamohara H; Ogawa M; Ishiko T; Sakamoto K; Baba H
Int J Oncol; 2007 Apr; 30(4):977-83. PubMed ID: 17332938
[TBL] [Abstract][Full Text] [Related]
15. Leukemia inhibitory factor protein and receptors are expressed in the bovine adrenal cortex and increase cortisol and decrease adrenal androgen release.
Woods AM; McIlmoil CJ; Rankin EN; Packer AA; Stevens JC; Macievic JA; Brown AB; Porter JP; Judd AM
Domest Anim Endocrinol; 2008 Aug; 35(2):217-30. PubMed ID: 18638665
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma.
Kausar T; Sharma R; Hasan MR; Saraya A; Chattopadhyay TK; Gupta SD; Ralhan R
Cell Oncol (Dordr); 2011 Jun; 34(3):177-87. PubMed ID: 21394648
[TBL] [Abstract][Full Text] [Related]
17. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas.
Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC
J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353
[TBL] [Abstract][Full Text] [Related]
18. Leukemia inhibitory factor ligand-receptor signaling is important for uterine receptivity and implantation in golden hamsters (Mesocricetus auratus).
Ding T; Song H; Wang X; Khatua A; Paria BC
Reproduction; 2008 Jan; 135(1):41-53. PubMed ID: 18159082
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo.
Rega G; Kaun C; Demyanets S; Pfaffenberger S; Rychli K; Hohensinner PJ; Kastl SP; Speidl WS; Weiss TW; Breuss JM; Furnkranz A; Uhrin P; Zaujec J; Zilberfarb V; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1587-95. PubMed ID: 17525365
[TBL] [Abstract][Full Text] [Related]
20. Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression.
Souazé F; Dupouy S; Viardot-Foucault V; Bruyneel E; Attoub S; Gespach C; Gompel A; Forgez P
Cancer Res; 2006 Jun; 66(12):6243-9. PubMed ID: 16778199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]